Nath Bio-Genes

Aurangabad, India Founded: 1979 • Age: 47 yrs Listed
Company that develops, produces, and markets hybrid and seeds for various crops, with a focus on improving crop yields
Request Access
Report Incorrect Data
Page last updated

About Nath Bio-Genes

Nath Bio-Genes is a publicly listed company based in Aurangabad (India) founded in 1979. Company that develops, produces, and markets hybrid and seeds for various crops, with a focus on improving crop yields. The company has 451 employees. Its Indian entity Nath Bio-Genes (India) Limited reported revenue of ₹459 Cr. Its focus areas include Food and Agriculture, Crop Inputs, Seeds and Diversified.

Company details

Nath Bio-Genes (I) Ltd is an Indian company engaged in the production, processing, and marketing of hybrid and genetically modified (GM) seeds. The company focuses on developing high-quality seeds for various crops, including oil seeds, fiber, and food grains. With a strong presence in the Indian market, Nath Bio-Genes aims to provide farmers with innovative and profitable seed solutions.

Operational Areas
Agriculture → Crop Inputs & Fertilizers
Key Metrics
  • Market Cap
    ₹252 Cr

    NATHBIOGEN · NSE

  • Share Price
    ₹131.01

    -1.03% today

  • Revenue
    ₹445 Cr

    FY 2025-26 · +22.0% YoY

  • EBITDA
    ₹52.44 Cr

    Margin 11.8%

  • Net Profit
    ₹36.24 Cr

    FY 2025-26 · -7.2% YoY

  • P/E (TTM)
    7.5x

    P/B 0.4x

  • Employee Count
    451

Apps and channels of Nath Bio-Genes

its YouTube channel Nath Bio-Genes India Limited has 4K subscribers and 30 videos.

Nath Bio-Genes India Limited
YouTube 4K subscribers 30 videos Autos & Vehicles
Open channel

Videos from Nath Bio-Genes

The most watched videos on Nath Bio-Genes's YouTube channel, Nath Bio-Genes India Limited (4K subscribers). Click a video to play it here.

నాథ్ విత్తనాలు అధిక దిగుబడిని మరియు పెద్ద బోల్ (పెద్ద కాయలు) రకం రానా 900ని ప్రవేశపెట్టాయి
59K views
Nath-20-20 Video
27.2K views
Nath Hybrid Bajra Super 27 #nathhybridbajra #nathbiogenes #nathseeds
12K views
Winall & Winpro Golii New Product Launching Video
3.6K views

More on Nath Bio-Genes India Limited.

Board of directors of Nath Bio-Genes (India) Limited (Nath Bio-Genes)

Nath Bio-Genes (India) Limited is the primary company behind Nath Bio-Genes. The board of Nath Bio-Genes (India) Limited currently have 7 directors; the longest-serving is Satish Laxminarayan Kagliwal, appointed in 2000. 13 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Satish Laxminarayan Kagliwal
DIN 00119601
Managing Director29 Mar 200026 yrs 7 moNath Bio-Genes (India) Limited
Jeevanlata Nandkishor Kagliwal
DIN 02057459
Director30 May 20197 yrs 5 moNath Bio-Genes (India) Limited
Vadla Nagabhushanam
DIN 08863512
Director07 Nov 20205 yrs 11 moNath Bio-Genes (India) Limited
Madhukar Dhondiraj Deshpande
DIN 07630081
Director10 Feb 20215 yrs 8 moNath Bio-Genes (India) Limited
Hitesh Rajnikant Purohit
DIN 02340858
Director30 Mar 20224 yrs 7 moNath Bio-Genes (India) Limited
Akash Nandkishor Kagliwal
DIN 01691724
Director22 Apr 20233 yrs 6 moNath Bio-Genes (India) Limited
Payal Dilipkumar Jain
DIN 09272201
Director11 Jul 20251 yr 3 moNath Bio-Genes (India) Limited

People of Nath Bio-Genes

7 people are tracked at Nath Bio-Genes (3 in leadership, 4 in team); the tracked headcount is 451.

NameRoleGroup
Satish Kagliwal
Managing DirectorLeadership
Harish Pandey
Country Head - Sales & MarketingLeadership
Devinder Khurana
Executive Vice PresidentLeadership
Srikanth Yadav
ExecutiveTeam
Santosh Ghanwat
Production ManagerTeam
Satish Korde
Territory Sales ManagerTeam
Miftaur Rahman
Territory Sales ManagerTeam
Premium access

Complete people profiles for Nath Bio-Genes

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Nath Bio-Genes

Nath Bio-Genes is a publicly listed company on the NSE with ticker symbol NATHBIOGEN in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date28 Jan 2014
  • Listed onNSE: NATHBIOGEN · BSE: 537291
  • Listed entityNath Bio-Genes (India) Ltd.
  • Exchange sectorProcess industries
  • ISININE448G01010
  • Share price₹140.00 (+3.25% on the day) · 2026-10-14
  • Market capitalisation₹258 Cr
  • Price to earnings6.9
  • EPS (diluted, trailing year)₹20.35
  • Dividend yield1.47%
  • Volume (last session)2,457

Financials of Nath Bio-Genes

Exchange-reported figures of Nath Bio-Genes (India) Limited, the listed company behind Nath Bio-Genes (NSE: NATHBIOGEN).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹445 Cr
+22.0% YoY
EBITDA
₹52.44 Cr
+5.0% YoY
Profit After Tax
₹36.24 Cr
-7.2% YoY
Net Worth
₹680 Cr
+5.6% YoY
Total Assets
₹824 Cr
+6.9% YoY
Total Debt
₹138 Cr
+13.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2012-13
Income statement
Revenue445365333301278138
Revenue growth+22.0%+9.7%+10.4%+8.3%--
EBITDA52.4449.9649.9548.83(51.56)19.90
EBITDA margin+11.8%+13.7%+15.0%+16.2%-18.5%+14.5%
Profit before tax46.3140.5841.5736.16(63.43)12.30
Net profit36.2439.0736.3335.0323.7411.75
Net profit margin+8.1%+10.7%+10.9%+11.6%+8.5%+8.5%
EPS (₹)20.9820.3120.8518.43(35.46)7.34
Balance sheet
Total assets82477072368163778.13
Net worth68064461057354257.47
Total debt13812311010592.9519.19
Cash & bank76.0088.9077.4138.004.182.48
Net working capital50543441540936639.60
Cash flow
Cash from operations(12.57)17.5874.5938.3717.05-
Cash from investing3.46(3.96)(27.40)(2.88)(19.85)-
Cash from financing(3.79)(2.13)(7.78)(1.67)(22.23)-
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue32851.5965.9643.8528451.9736.8732.19
Revenue growth (YoY)+15.8%-0.7%+78.9%+36.2%+16.3%---
Other income3.103.634.424.003.834.400.480.08
EBITDA35.154.473.576.1029.280.428.034.81
EBITDA margin+10.7%+8.7%+5.4%+13.9%+10.3%+0.8%+21.8%+14.9%
Depreciation1.011.030.980.990.981.340.830.83
Interest4.264.594.543.663.201.373.902.98
Profit before tax32.982.482.475.4528.932.113.781.08
Tax0.722.500.870.640.660.631.14(0.03)
Net profit32.26(0.02)1.604.8128.271.482.641.11
EPS (₹)16.98(0.79)0.892.5314.880.421.330.53
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue432362333301278308280
Revenue growth+19.1%+8.9%+10.4%+8.2%-9.5%+9.9%-
EBITDA52.5452.4050.4848.98(51.51)66.7654.80
EBITDA margin+12.2%+14.5%+15.2%+16.3%-18.5%+21.7%+19.6%
Profit before tax49.1044.1342.1336.32(63.38)56.7448.52
Net profit38.9942.6236.8935.1723.7955.6550.47
Net profit margin+9.0%+11.8%+11.1%+11.7%+8.6%+18.1%+18.0%
EPS (₹)23.3822.1721.1418.50(35.43)29.2926.56
Balance sheet
Total assets816763722681638717630
Net worth689649611573542613558
Total debt12211110810592.9510170.15
Cash & bank70.6787.6375.5037.984.1729.2221.98
Net working capital497427413409366463373
Cash flow
Cash from operations(13.91)26.8074.7238.3717.051.119.48
Cash from investing3.46(4.05)(27.40)(2.88)(19.87)(10.28)(14.44)
Cash from financing(6.51)(10.62)(9.81)(1.67)(22.23)16.405.56
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue32345.6965.9639.7728049.3736.8732.19
Revenue growth (YoY)+15.2%-7.5%+78.9%+23.6%+14.9%---
Other income3.103.634.421.933.834.580.480.07
Total expenses28839.0857.1332.5825046.2029.3625.63
EBITDA35.076.618.837.1929.903.177.516.56
EBITDA margin+10.9%+14.5%+13.4%+18.1%+10.7%+6.4%+20.4%+20.4%
Depreciation1.011.020.980.980.981.320.830.83
Interest3.792.944.183.302.891.103.372.94
Profit before tax33.376.288.094.8429.865.333.792.86
Tax0.722.500.870.640.660.631.14(0.03)

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 01 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue32851.5965.9643.8528451.9736.8732.19
Revenue growth (YoY)+15.8%-0.7%+78.9%+36.2%+16.3%---
Other income3.103.634.424.003.834.400.480.08
EBITDA35.154.473.576.1029.280.428.034.81
EBITDA margin+10.7%+8.7%+5.4%+13.9%+10.3%+0.8%+21.8%+14.9%
Depreciation1.011.030.980.990.981.340.830.83
Interest4.264.594.543.663.201.373.902.98
Profit before tax32.982.482.475.4528.932.113.781.08
Tax0.722.500.870.640.660.631.14(0.03)
Net profit32.26(0.02)1.604.8128.271.482.641.11
EPS (₹)16.98(0.79)0.892.5314.880.421.330.53
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2012-13
Revenue445365333301278138
Revenue growth+22.0%+9.7%+10.4%+8.3%--
Other income13.825.094.080.551.850.58
Total expenses393315283253330118
Employee cost0.0031.8327.5823.3224.7810.22
EBITDA52.4449.9649.9548.83(51.56)19.90
EBITDA margin+11.8%+13.7%+15.0%+16.2%-18.5%+14.5%
Depreciation3.963.823.263.013.084.51
Interest15.9910.659.2010.2110.643.67
Profit before tax46.3140.5841.5736.16(63.43)12.30
Tax4.671.981.951.153.950.55
Net profit36.2439.0736.3335.0323.7411.75
Net profit margin+8.1%+10.7%+10.9%+11.6%+8.5%+8.5%
EPS (₹)20.9820.3120.8518.43(35.46)7.34
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2012-13
Equity & liabilities
Share capital19.0019.0019.0019.0019.0016.00
Reserves & surplus66162559155452341.47
Shareholders' funds (net worth)68064461057354257.47
Minority interest0.000.000.00(0.02)0.000.00
Secured loans95.0610610310491.0714.75
Unsecured loans43.4416.256.951.031.884.44
Total debt13812311010592.9519.19
Total liabilities82477072368163778.13
Assets
Gross block27527927427026776.75
Net block24925024924424537.62
Capital work in progress0.020.000.000.000.000.00
Investments5.905.786.055.055.050.00
Inventories45133823020822077.17
Sundry debtors85.4188.9094.3197.3185.5520.99
Cash & bank balances76.0088.9077.4138.004.182.48
Loans & advances16717417017815819.11
Total current assets779690572521468120
Total current liabilities27425615711210280.15
Net working capital50543441540936639.60
Total assets82477072368163778.13
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2012-13
Opening cash88.9077.4138.004.1829.22-
Net cash from operating activities(12.57)17.5874.5938.3717.05-
Net cash from investing activities3.46(3.96)(27.40)(2.88)(19.85)-
Net cash from financing activities(3.79)(2.13)(7.78)(1.67)(22.23)-
Net change in cash(12.90)11.4939.4133.81(25.04)-
Closing cash76.0088.9077.4138.004.18-
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2012-13
Growth
Sales growth+22.0%+9.7%+10.4%+8.3%--
EBITDA growth+5.0%+0.0%+2.3%+194.7%--
PBT growth+14.1%-2.4%+15.0%+9998.0%-+9997.0%
Net income growth-7.2%+7.5%+3.7%+47.6%--
Revenue CAGR (3Y)+13.9%+9.4%+34.2%---
EBITDA CAGR (3Y)+2.4%-+35.9%---
Profitability & leverage
Net income margin+9.4%+10.6%+11.9%+11.6%-24.2%+8.5%
Return on capital employed-+6.9%+7.2%+7.0%+5.6%+23.4%
Return on net worth-+6.2%+6.7%+6.3%+4.4%+22.8%
Debt / equity-0.190.180.180.170.29
Long-term debt / equity-0.010.000.000.000.02
Interest cover32.9823.0819.7022.28-19.4723.85
Efficiency & per share
Fixed asset turnover-1.321.221.121.042.08
Inventory turnover-1.281.521.411.261.93
Debtors turnover-3.983.473.303.258.24
EPS (₹)20.9820.3120.8518.43(35.46)7.34
Dividend per share (₹)2.002.002.002.002.000.00
Book value per share (₹)0.00339.08320.94301.61285.1635.91
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue32345.6965.9639.7728049.3736.8732.19
Revenue growth (YoY)+15.2%-7.5%+78.9%+23.6%+14.9%---
Other income3.103.634.421.933.834.580.480.07
Total expenses28839.0857.1332.5825046.2029.3625.63
EBITDA35.076.618.837.1929.903.177.516.56
EBITDA margin+10.9%+14.5%+13.4%+18.1%+10.7%+6.4%+20.4%+20.4%
Depreciation1.011.020.980.980.981.320.830.83
Interest3.792.944.183.302.891.103.372.94
Profit before tax33.376.288.094.8429.865.333.792.86
Tax0.722.500.870.640.660.631.14(0.03)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue432362333301278308280
Revenue growth+19.1%+8.9%+10.4%+8.2%-9.5%+9.9%-
Other income13.825.274.100.561.851.671.82
Total expenses379310282252330241225
Employee cost0.0029.6427.3123.2324.7823.6918.74
EBITDA52.5452.4050.4848.98(51.51)66.7654.80
EBITDA margin+12.2%+14.5%+15.2%+16.3%-18.5%+21.7%+19.6%
Depreciation3.953.793.263.013.082.821.45
Interest13.319.759.1910.2110.648.876.65
Profit before tax49.1044.1342.1336.32(63.38)56.7448.52
Tax4.671.981.951.153.951.09(1.98)
Net profit38.9942.6236.8935.1723.7955.6550.47
Net profit margin+9.0%+11.8%+11.1%+11.7%+8.6%+18.1%+18.0%
EPS (₹)23.3822.1721.1418.50(35.43)29.2926.56
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital19.0019.0019.0019.0019.0019.0019.00
Reserves & surplus670630592554523594539
Shareholders' funds (net worth)689649611573542613558
Secured loans95.0610610310491.0788.6363.37
Unsecured loans26.674.884.911.031.8812.156.78
Total debt12211110810592.9510170.15
Total liabilities816763722681638717630
Assets
Gross block275279274270267267265
Net block249250249244245247246
Capital work in progress0.020.000.000.000.000.000.00
Investments6.176.056.065.065.065.055.00
Inventories445331229208220226204
Sundry debtors83.7988.8494.3197.3185.55109107
Cash & bank balances70.6787.6375.5037.984.1729.2221.98
Loans & advances165173170178158171139
Total current assets764681569521468536472
Total current liabilities26725415511210272.8799.77
Net working capital497427413409366463373
Total assets816763722681638717630
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash87.6375.5037.984.1729.2221.9821.38
Net cash from operating activities(13.91)26.8074.7238.3717.051.119.48
Net cash from investing activities3.46(4.05)(27.40)(2.88)(19.87)(10.28)(14.44)
Net cash from financing activities(6.51)(10.62)(9.81)(1.67)(22.23)16.405.56
Net change in cash(16.97)12.1337.5233.82(25.05)7.230.61
Closing cash70.6787.6375.5037.984.1729.2221.98
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+19.1%+8.9%+10.4%+8.2%-9.5%+9.9%-
EBITDA growth+0.3%+3.8%+3.1%+195.1%-177.2%+21.8%-
PBT growth+11.3%+4.8%+16.0%+9998.0%-+16.9%+24.9%
Net income growth-8.5%+15.5%+4.9%+47.8%-57.3%+10.3%-
Revenue CAGR (3Y)+12.7%+9.2%+2.7%+2.5%+6.4%+17.1%+18.1%
EBITDA CAGR (3Y)+2.4%--8.9%-3.7%-+18.2%+23.6%
Profitability & leverage
Net income margin+10.3%+11.6%+12.1%+11.7%-24.2%+18.1%+18.0%
Return on capital employed-+7.3%+7.3%+7.1%+5.3%+9.7%+9.2%
Return on net worth-+6.7%+6.8%+6.3%+4.1%+9.5%+9.5%
Debt / equity-0.170.180.180.170.150.12
Long-term debt / equity-0.000.000.00-7,615.540.000.00
Interest cover27.3920.0619.4622.21-19.4913.8712.46
Efficiency & per share
Fixed asset turnover-1.311.221.121.041.161.09
Inventory turnover-1.291.521.411.251.431.56
Debtors turnover-3.963.473.302.862.842.60
EPS (₹)23.3822.1721.1418.50(35.43)29.2926.56
Dividend per share (₹)2.002.002.002.002.002.000.00
Book value per share (₹)0.00341.33321.33301.70285.19322.71293.42

Web traffic of Nath Bio-Genes

The website of Nath Bio-Genes (nathbiogenes.com) receives about 1.9K visits a month.

  • Monthly visits
    1.9K

    ▼ 18.9% vs previous month

Similar websites

Websites whose visitors overlap most with Nath Bio-Genes. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
Chromecast
google.co.in
100%
77M#407View details
Facebook
facebook.com
100%
12.1B#3View details

Top companies in Crop Inputs & Fertilizers

3 companies that operate in the same segment as Nath Bio-Genes (Crop Inputs & Fertilizers) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
DFPCL
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate
1979Pune, Maharashtra, IndiaUSD 1.21 B1,020
Safex Chemicals
Manufacturer of agrochemicals for crop protection
1991Delhi, Delhi, IndiaUSD 88.79 MUSD 165.62 M449
Crystal Crop Protection
Agrochemicals and equipment for crop protection are manufactured.
1994Delhi, Delhi, IndiaUSD 28.03 MUSD 303.27 M1,262
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Nath Bio-Genes

Nath Bio-Genes (India) June-Quarter Consol Net Profit 322.6 Million Rupees
Reuters • 3 months ago
Nath Bio-Genes (India) consolidated net profit rises 11.78% in the June 2025 quarter | Capital Market News - Business Standard
Business Standard • 1 year ago
Nath Bio-Genes (India) standalone net profit rises 19.51% in the September 2022 quarter
India Infoline • 1 year ago
Jain Irrigation gains on deal with Indian Coffee Board
Reuters • 2 years ago
Nath Bio-Genes (I) June-Quarter Consol Net Profit At 333.5 Million Rupees
Reuters • 2 years ago
India's Nath Bio-Genes (I) June-Quarter Consol Net Profit Rises
Reuters • 3 years ago
India Ratings Rates Nath Bio-Genes (India)’s Additional Limits and Affirms Existing Ratings at ‘IND BBB-’/Positive
Indiaratings • 3 years ago
India Ratings Affirms Nath Bio-Genes (India) at ‘IND BBB-’/Positive; Off Rating Watch with Negative Implications
Indiaratings • 3 years ago
Update on Nath Bio-Genes (India) Limited
Indiaratings • 3 years ago
Nath Bio-Genes (I) Ltd-June Quarter Net Profit Rises
Reuters • 5 years ago
Premium access

Complete news archive for Nath Bio-Genes

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Articles about Nath Bio-Genes on our blog

Frequently Asked Questions about Nath Bio-Genes

Nath Bio-Genes was founded in 1979.

Nath Bio-Genes is headquartered in Aurangabad, India. It is registered at Aurangabad, Maharashtra, India.

Nath Bio-Genes has 451 employees.

The primary company behind Nath Bio-Genes, Nath Bio-Genes (India) Limited, reported revenue of ₹459 Cr for FY 2026, up 22% year on year.

Nath Bio-Genes (I) Ltd is an Indian company engaged in the production, processing, and marketing of hybrid and genetically modified (GM) seeds. The company focuses on developing high-quality seeds for various crops, including oil seeds, fiber, and food grains. With a strong presence in the Indian market, Nath Bio-Genes aims to provide farmers with innovative and profitable seed solutions.

Yes, Nath Bio-Genes is publicly traded on NSE under the ticker symbol NATHBIOGEN.

Nath Bio-Genes operates through Nath Bio-Genes (India) Limited.

The legal entities of Nath Bio-Genes currently have 9 directors, including Satish Laxminarayan Kagliwal, Madhukar Dhondiraj Deshpande, Jeevanlata Nandkishor Kagliwal and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available